Tibet Weixinkang Medicine Co., Ltd.

Shanghai Stock Exchange 603676.SS

Tibet Weixinkang Medicine Co., Ltd. Dividend Yield on January 14, 2025: 2.40%

Tibet Weixinkang Medicine Co., Ltd. Dividend Yield is 2.40% on January 14, 2025, a 5.13% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Tibet Weixinkang Medicine Co., Ltd. 52-week high Dividend Yield is 3.42% on February 07, 2024, which is 42.60% above the current Dividend Yield.
Tibet Weixinkang Medicine Co., Ltd. 52-week low Dividend Yield is 2.06% on November 07, 2024, which is -14.13% below the current Dividend Yield.
Tibet Weixinkang Medicine Co., Ltd. average Dividend Yield for the last 52 weeks is 2.64%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

Shanghai Stock Exchange: 603676.SS

Tibet Weixinkang Medicine Co., Ltd.

CEO	Mr. Yong Zhang
IPO Date	July 21, 2017
Location	China
Headquarters	Building 4
Employees	701
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company's products include parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, antibiotics, and medicine for digestive system and liver diseases. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2006 and is based in Lhasa, China.

Key trends

Past 5 years